Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aileron Therapeutics Inc (NQ: ALRN )

0.6650 USD -0.0065 (-0.97%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 404,944
Open 0.6715
Bid (Size) 0.6994 (1)
Ask (Size) 0.7190 (20)
Prev. Close 0.6715
Today's Range 0.6351 - 0.7080
52wk Range 0.5862 - 2.330
Shares Outstanding 90,573,597
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
From GlobeNewswire News Releases
Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924’s Best-in-Class Potential as a Chemoprotective Agent
From GlobeNewswire News Releases

Performance

YTD
-36.67%
-36.67%
1 Month
-22.51%
-22.51%
3 Month
-39.55%
-39.55%
6 Month
-47.22%
-47.22%
1 Year
-38.99%
-38.99%

More News

Read More
Aileron Therapeutics to Present New Clinical Data at ESMO Virtual Congress 2021 Supporting Novel, Selective Chemoprotective Agent ALRN-6924
From GlobeNewswire News Releases
Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference
From GlobeNewswire News Releases
Aileron Therapeutics Presents Initial Findings from Ongoing Healthy Volunteer Study of ALRN-6924 at ISEH 50th Annual Scientific Meeting
From GlobeNewswire News Releases
Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
From GlobeNewswire News Releases
Aileron Therapeutics Announces Initiation of Randomized, Double-Blind, Placebo-Controlled Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags KTTA Market News BIOL
From Benzinga
Aileron Therapeutics to be Added to the Russell Microcap® Index
From GlobeNewswire News Releases
Aileron Therapeutics to Host KOL Virtual Investor Event Discussing Opportunity for New Paradigm to Protect Cancer Patients from Chemotherapy-Induced Toxicities
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.